Key Takeaways
- • Troutman Pepper Locke climbed 16 spots in The Deal's Q2 2026 Private Equity League Tables, reaching No. 18 nationally, demonstrating significant momentum in private equity advisory positioning.
- • The firm achieved No. 18 ranking in U.S. private equity deal activity and No. 12 in representing U.S. companies according to PitchBook's Q2 2026 Global League Tables, both improvements from Q1 2026.
- • Regional strength concentrated in the South, where Troutman Pepper Locke ranked No. 5 most active; the firm also secured No. 11 ranking in energy sector deals and No. 17 in healthcare—key institutional investor segments.
- • Venture capital presence expanded with No. 10 ranking in health care devices and supplies and No. 11 in health care services and systems, signaling diversification across healthcare subsectors.
- • Sequential quarter-over-quarter improvements across multiple deal league tables reflect expanding client relationships and increased practice activity heading into the second half of 2026.
Summary
Troutman Pepper Locke strengthened its position among top-tier legal advisors to institutional investors in the first half of 2026, posting notable gains across private equity, venture capital, and M&A league tables released by major tracking firms. The firm's most significant advancement came in The Deal's Q2 2026 Private Equity League Tables, where it rose 16 positions to No. 18 nationally—a substantial climb that underscores increased deal flow and client mandate wins in the private equity space.
Across PitchBook's Q2 2026 Global League Tables, Troutman Pepper Locke demonstrated broad-based strength across both geography and sector. The firm ranked No. 18 most active in U.S. private equity transactions and No. 12 most active in representing U.S. companies, both metrics improving from prior quarter. Regional breakdowns reveal concentrated activity in the South, where the firm achieved No. 5 status—its strongest regional positioning. Sector expertise showed particular depth in energy, where Troutman Pepper Locke ranked No. 11 globally, alongside No. 17 in healthcare and No. 23 in business-to-business transactions.
The firm's venture capital credentials strengthened as well, with top-10 and top-15 rankings in healthcare-focused subsectors: No. 10 in health care devices and supplies and No. 11 in health care services and systems. This positioning reflects meaningful institutional activity in healthcare venture deals, a sector that continues to attract substantial capital from family offices and specialized venture funds.
Paul Mahoney, leader of Troutman Pepper Locke's Private Equity and Investment Funds Practice, attributed the consecutive quarter-over-quarter improvements to deepening client relationships and increased practice activation across multiple industries and geographies. The sequential gains suggest that the firm's deal volume and mandate depth are expanding as market conditions stabilize in the second half of 2026, relevant to institutional investors evaluating legal counsel depth and track record in capital deployment.
Across PitchBook's Q2 2026 Global League Tables, Troutman Pepper Locke demonstrated broad-based strength across both geography and sector. The firm ranked No. 18 most active in U.S. private equity transactions and No. 12 most active in representing U.S. companies, both metrics improving from prior quarter. Regional breakdowns reveal concentrated activity in the South, where the firm achieved No. 5 status—its strongest regional positioning. Sector expertise showed particular depth in energy, where Troutman Pepper Locke ranked No. 11 globally, alongside No. 17 in healthcare and No. 23 in business-to-business transactions.
The firm's venture capital credentials strengthened as well, with top-10 and top-15 rankings in healthcare-focused subsectors: No. 10 in health care devices and supplies and No. 11 in health care services and systems. This positioning reflects meaningful institutional activity in healthcare venture deals, a sector that continues to attract substantial capital from family offices and specialized venture funds.
Paul Mahoney, leader of Troutman Pepper Locke's Private Equity and Investment Funds Practice, attributed the consecutive quarter-over-quarter improvements to deepening client relationships and increased practice activation across multiple industries and geographies. The sequential gains suggest that the firm's deal volume and mandate depth are expanding as market conditions stabilize in the second half of 2026, relevant to institutional investors evaluating legal counsel depth and track record in capital deployment.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.